Yueyu Fang

Circ_0000376 enhances the proliferation, metastasis, and chemoresistance of NSCLC cells via repressing miR-384.

Chun Jiang, Yi Chen, X. Qiao, 2020, Cancer biomarkers : section A of Disease markers.

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors

Wensen Chen, P. Seesaha, Xiaofeng Chen, 2022, Medicine.

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11

Junfeng Shi, Weiwei Tang, Yinxin Zhu, 2021, Bioengineered.

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway

Junfeng Shi, Hanjin Wang, W. Liang, 2022, Bioengineered.

Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial

Yong-bin Ding, Xiao-Feng Chen, Guo-Qun Wang, 2021, OncoTargets and therapy.

A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient

Junfeng Shi, Hui Sun, Yueyu Fang, 2021, Medicine.